AR222290A1 - Procedimiento para obtener derivados de 5-het'-metil-2-het-metiltio-etilamino o 2-het-butilamino pirimidin-4-ona - Google Patents

Procedimiento para obtener derivados de 5-het'-metil-2-het-metiltio-etilamino o 2-het-butilamino pirimidin-4-ona

Info

Publication number
AR222290A1
AR222290A1 AR266049A AR26604976A AR222290A1 AR 222290 A1 AR222290 A1 AR 222290A1 AR 266049 A AR266049 A AR 266049A AR 26604976 A AR26604976 A AR 26604976A AR 222290 A1 AR222290 A1 AR 222290A1
Authority
AR
Argentina
Prior art keywords
het
methyltio
pirimidin
ona
butylamine
Prior art date
Application number
AR266049A
Other languages
English (en)
Spanish (es)
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Application granted granted Critical
Publication of AR222290A1 publication Critical patent/AR222290A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AR266049A 1975-12-29 1976-12-29 Procedimiento para obtener derivados de 5-het'-metil-2-het-metiltio-etilamino o 2-het-butilamino pirimidin-4-ona AR222290A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5300175 1975-12-29

Publications (1)

Publication Number Publication Date
AR222290A1 true AR222290A1 (es) 1981-05-15

Family

ID=10466233

Family Applications (1)

Application Number Title Priority Date Filing Date
AR266049A AR222290A1 (es) 1975-12-29 1976-12-29 Procedimiento para obtener derivados de 5-het'-metil-2-het-metiltio-etilamino o 2-het-butilamino pirimidin-4-ona

Country Status (37)

Country Link
JP (1) JPS5283388A (hu)
AR (1) AR222290A1 (hu)
AT (1) AT360024B (hu)
AU (1) AU508123B2 (hu)
BE (1) BE849810A (hu)
BG (1) BG29722A3 (hu)
CA (1) CA1073458A (hu)
CH (1) CH631981A5 (hu)
CS (1) CS203995B2 (hu)
DD (1) DD128588A5 (hu)
DE (1) DE2658267A1 (hu)
DK (1) DK587076A (hu)
EG (1) EG12439A (hu)
ES (1) ES454656A1 (hu)
FI (1) FI62668C (hu)
FR (1) FR2336935A1 (hu)
GR (1) GR62441B (hu)
HU (1) HU175171B (hu)
IE (1) IE45082B1 (hu)
IL (1) IL51040A (hu)
IT (2) IT1124740B (hu)
LU (1) LU76481A1 (hu)
MW (1) MW5076A1 (hu)
MX (1) MX5119E (hu)
NL (1) NL7614538A (hu)
NO (1) NO146396C (hu)
NZ (1) NZ182759A (hu)
OA (1) OA05526A (hu)
PH (1) PH14723A (hu)
PL (1) PL104376B1 (hu)
PT (1) PT65949B (hu)
RO (1) RO72475A (hu)
SE (1) SE431544B (hu)
SU (1) SU791235A3 (hu)
YU (1) YU311676A (hu)
ZA (1) ZA767198B (hu)
ZM (1) ZM14376A1 (hu)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ186511A (en) 1977-03-19 1980-11-14 Smith Kline French Lab 3-substituted alkylamino-6-substituted alkyl-1,2,4-triazin-5-ones and pharmaceutical compositions 3-substituted thio-1,2,4-triazin-5-ones
IL56265A (en) * 1977-12-28 1982-08-31 Om Lab Sa Process for preparing imidazolyl methylthio guanidine derivatives and a novel intermediate therefor
IN151188B (hu) * 1978-02-13 1983-03-05 Smith Kline French Lab
US4539207A (en) * 1978-02-13 1985-09-03 Smith Kline & French Laboratories Limited Pyrimidine compounds
IL57005A (en) * 1978-04-11 1983-11-30 Smith Kline French Lab Process for the preparation of 2-amino pyrimid-4-one derivatives and novel 2-nitroaminopyrimid-4-ones as intermediates therefor
ZA792607B (en) * 1978-05-30 1980-07-30 Smith Kline French Lab Nitro compounds
PT69886A (en) * 1978-07-15 1979-08-01 Smith Kline French Lab Process for preparing isoureas and isothioureas
US4374836A (en) 1978-10-16 1983-02-22 Imperial Chemical Industries Ltd. Antisecretory heterocyclic derivatives, process for their manufacture and pharmaceutical compositions containing them
US4309435A (en) 1978-10-16 1982-01-05 Imperial Chemical Industries Ltd. Antisecretory guanidine derivatives and pharmaceutical compositions containing them
US4496567A (en) * 1978-11-13 1985-01-29 Smith Kline & French Laboratories Limited Phenyl alkylaminopyrimidones
US4521418A (en) * 1979-02-21 1985-06-04 Smith Kline & French Laboratories Limited Guanidinothiazolyl derivatives
US4255428A (en) 1979-03-24 1981-03-10 Smith Kline & French Laboratories Limited 5-(Hydroxypyridylalkyl)-4-pyrimidones
JPS55133379A (en) * 1979-04-05 1980-10-17 Smith Kline French Lab Pyrimidone compound
EP0017680B1 (en) * 1979-04-11 1982-04-21 Smith Kline & French Laboratories Limited Pyrimidone derivatives, process for preparing them and pharmaceutical compositions containing them
JPS55145683A (en) * 1979-04-26 1980-11-13 Smith Kline French Lab Pyrimidone derivative
CA1155842A (en) * 1980-03-29 1983-10-25 Thomas H. Brown Compounds
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
IE53068B1 (en) * 1981-06-15 1988-05-25 Merck & Co Inc Diamino isothiazole-1-oxides and -1,1-dioxides as gastic secretion inhibitors
PT75074B (en) * 1981-06-27 1986-02-26 Smith Kline French Lab Process for preparing certain pyrimidone derivatives and compositions containing them
US6417366B2 (en) * 1999-06-24 2002-07-09 Abbott Laboratories Preparation of quinoline-substituted carbonate and carbamate derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
IN146736B (hu) * 1975-10-02 1979-08-25 Smith Kline French Lab

Also Published As

Publication number Publication date
BG29722A3 (en) 1981-01-15
FI62668B (fi) 1982-10-29
NO146396C (no) 1982-09-22
JPS6129355B2 (hu) 1986-07-05
IE45082B1 (en) 1982-06-16
OA05526A (fr) 1981-04-30
RO72475A (ro) 1982-10-26
HU175171B (hu) 1980-05-28
IL51040A (en) 1980-12-31
JPS5283388A (en) 1977-07-12
ATA960876A (de) 1980-05-15
CH631981A5 (en) 1982-09-15
NO764370L (hu) 1977-06-30
FR2336935B1 (hu) 1980-03-21
EG12439A (en) 1979-09-30
AT360024B (de) 1980-12-10
PL104376B1 (pl) 1979-08-31
ZA767198B (en) 1977-11-30
PH14723A (en) 1981-11-13
CA1073458A (en) 1980-03-11
IE45082L (en) 1977-06-29
SE7614620L (sv) 1977-06-30
YU311676A (en) 1983-01-21
ES454656A1 (es) 1977-11-16
FR2336935A1 (fr) 1977-07-29
LU76481A1 (hu) 1977-06-15
CS203995B2 (en) 1981-03-31
MW5076A1 (en) 1978-02-08
IL51040A0 (en) 1977-02-28
PT65949A (pt) 1977-01-01
NZ182759A (en) 1978-06-02
FI62668C (fi) 1983-02-10
SU791235A3 (ru) 1980-12-23
AU2097676A (en) 1978-07-06
DD128588A5 (de) 1977-11-30
AU508123B2 (en) 1980-03-13
NL7614538A (nl) 1977-07-01
NO146396B (no) 1982-06-14
BE849810A (fr) 1977-06-23
DE2658267A1 (de) 1977-07-07
ZM14376A1 (en) 1977-08-22
GR62441B (en) 1979-04-12
IT1124740B (it) 1986-05-14
IT7919107A0 (it) 1979-01-05
SE431544B (sv) 1984-02-13
MX5119E (es) 1983-03-24
DK587076A (da) 1977-06-30
FI763664A (hu) 1977-06-30
PT65949B (pt) 1978-06-15

Similar Documents

Publication Publication Date Title
MX4717E (es) Procedimiento para la preparacion de derivados de pirrolidina
AR213097A1 (es) Procedimiento para preparar derivados de la 1,4-dihidropirina
MX4488E (es) Procedimiento para la preparacion de derivados de quinazolona
AR222290A1 (es) Procedimiento para obtener derivados de 5-het'-metil-2-het-metiltio-etilamino o 2-het-butilamino pirimidin-4-ona
MX4811E (es) Procedimiento para preparar derivados de prostaglandina
AR220344A1 (es) Procedimiento para obtener derivados de 1-sulfonil-2-aminobenzimidazol-5(6)-sustituido
MX4614E (es) Procedimiento mejorado para la preparacion de derivados de pirimidina
AR230059A1 (es) Procedimiento para obtener derivados de piperidil-1-il-alcoxi o hidroxialcoxi-carboestirilo o 3,4-dihidrocarboestirilo
AR213736A1 (es) Procedimiento para la preparacion de(2-(3 o 4)-alcoxi-2-piridil-(metiltio o etil)etil)-(ciano-guanidina o alquilaminonitroetileno)
MX143488A (es) Procedimiento para la preparacion de resorcinas
AR211887A1 (es) Procedimiento para la preparacion de derivados de endolizina
AR217629A1 (es) Procedimiento de preparacion de derivados de tienotetrahidropiridina
AR221081A1 (es) Procedimiento para preparar derivados de fenoximetil-piperidino-propoxi-indol
AR224110A1 (es) Procedimiento para la preparacion de derivados de 5(6)-benzimidazoles
MX4664E (es) Procedimiento mejorado para la preparacion de derivados de n-fosfonometilglicina
MX3636E (es) Procedimiento para la preparacion de propargil-2-fenilamino-imidazolinas-(2)
AR213831A1 (es) Procedimiento para la preparacion de 11-desoxi-16-aril-omega-tetranorprostaglandina
MX4796E (es) Procedimiento para la preparacion de derivados de 2-iminotiazolina
MX4133E (es) Procedimiento para la preparacion de n-tetrahidrofurfuril-noroximorfonas diastereoisomeras
AR211570A1 (es) Procedimiento de preparacion de nuevos derivados de 8-oxi-5-(2-hidroxi-3-aminopropoxi)-carbostirilo
AR208361A1 (es) Procedimiento para la preparacion de derivados l-piroglutamil-l-histidil-3-alquil-prolinamida
AR209498A1 (es) Procedimiento para la preparacion de l-piroglutamil-l-pronilamida
AR217664A1 (es) Procedimiento para la preparacion de derivados de oleandomicina
MX3798E (es) Procedimiento para preparar esteres 17-ol de 17-alfa-etinil-4-estren-3-onas o 17 beta-acetil-4-pregnen-3-onas
MX5191E (es) Procedimiento para la preparacion de derivados de n'-fenil-n-metilurea